123 related articles for article (PubMed ID: 8692670)
1. [A preliminary study of percutaneous ethanol injection therapy for hepatocellular carcinoma: evaluation of the ethanol diffusion area by the ethanol mixed with gadolinium].
Matsumura K; Kiyota K; Inokuchi H; Tahashi Y; Hirota M; Habu Y; Takazakura R; Ohnaka Y; Furukawa A
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Jun; 56(7):517-9. PubMed ID: 8692670
[TBL] [Abstract][Full Text] [Related]
2. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
[TBL] [Abstract][Full Text] [Related]
3. [Percutaneous hot ethanol injection therapy (PHEIT) for hepatocellular carcinoma].
Nakai M; Sato M; Yamada K; Ishii S; Minamiguchi H; Kimura M; Kishi K; Terada M; Kawai N
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1633-7. PubMed ID: 11707997
[TBL] [Abstract][Full Text] [Related]
4. [Percutaneous ethanol injection therapy (PEIT) and transarterial embolization (TAE) for recurrent hepatocellular carcinoma--report of 2 cases].
Ohashi I; Sasaki Y; Imaoka S; Masutani S; Ogawa A; Iwamoto S; Ohigashi H; Ishikawa O; Iwanaga T; Kasugai H
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1912-5. PubMed ID: 1652229
[TBL] [Abstract][Full Text] [Related]
5. Appraisal of combination treatment for hepatocellular carcinoma: long-term follow-up and lipiodol-percutaneous ethanol injection therapy.
Tateishi H; Oi H; Masuda N; Yano H; Matsui S; Kinuta M; Maruyama H; Yayoi E; Okamura J
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-81-S6-90. PubMed ID: 9151921
[TBL] [Abstract][Full Text] [Related]
6. [Studies on combination therapy with TAE and percutaneous ethanol injection therapy for unresectable hepatocellular carcinoma].
Tateishi H; Hasuike Y; Kinuta M; Furukawa J; Takata N; Maruyama H; Oi H; Yayoi E; Okamura J
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1492-4. PubMed ID: 8396903
[TBL] [Abstract][Full Text] [Related]
7. [A patient with HCC successfully treated by ethanol injection therapy with etoposide].
Sakon M; Kishimoto S; Aoki T; Okuyama M; Shimizu J; Yamada T; Higaki N; Taniguchi K; Takeda H; Sugimoto K; Dohno K; Osato H; Umeshita K; Gotoh M; Monden M
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1585-7. PubMed ID: 8854812
[TBL] [Abstract][Full Text] [Related]
8. Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence.
Horigome H; Nomura T; Saso K; Itoh M
Am J Gastroenterol; 1999 Jul; 94(7):1914-7. PubMed ID: 10406259
[TBL] [Abstract][Full Text] [Related]
9. Small hepatocellular carcinoma treated with percutaneous ethanol injection: unenhanced and gadolinium-enhanced MR imaging follow-up.
Sironi S; De Cobelli F; Livraghi T; Villa G; Zanello A; Taccagni G; DelMaschio A
Radiology; 1994 Aug; 192(2):407-12. PubMed ID: 8029405
[TBL] [Abstract][Full Text] [Related]
10. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?
Goshima S; Kanematsu M; Kondo H; Yokoyama R; Tsuge Y; Shiratori Y; Onozuka M; Moriyama N
J Magn Reson Imaging; 2008 Apr; 27(4):834-9. PubMed ID: 18383261
[TBL] [Abstract][Full Text] [Related]
11. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
[TBL] [Abstract][Full Text] [Related]
12. [Non-surgical (medical) treatment of hepatocellular carcinoma (HCC)].
Tanikawa K
Gan To Kagaku Ryoho; 1989 Jan; 16(1):34-9. PubMed ID: 2536269
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous ethanol injection therapy for hepatocellular carcinoma: validity of MR imaging in the evaluation of treatment effect.
Usui H; Itai Y
Radiat Med; 1995; 13(3):103-8. PubMed ID: 7569000
[TBL] [Abstract][Full Text] [Related]
15. [Combined therapy with transcatheter chemo-embolization and percutaneous ethanol injection].
Nakamura H; Hashimoto T; Suyama Y; Akaji H; Inoue K; Sawada S
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1740-3. PubMed ID: 2167646
[TBL] [Abstract][Full Text] [Related]
16. MR imaging of the liver before and after transcatheter hepatic chemo-embolization for hepatocellular carcinoma.
Yoshioka H; Nakagawa K; Shindou H; Ono Y; Kawakami A; Mabuchi N; Arita S; Fujii K; Hamada T; Ishida O
Acta Radiol; 1990 Jan; 31(1):63-7. PubMed ID: 2160264
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of transarterial embolization combined with percutaneous ethanol injection therapy for recurrent hepatocellular carcinoma].
Shimamura T; Une Y; Nakajima Y; Sato N; Matsushita M; Kamiyama T; Uchino J
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2229-32. PubMed ID: 7944447
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of combined therapy with chemoembolization and ethanol injection for advanced hepatocellular carcinoma.
Yamamoto K; Masuzawa M; Kato M; Kurosawa K; Kaneko A; Ishida H; Imamura E; Park NJ; Shirai Y; Fujimoto K; Michida T; Hayashi N; Ikeda M
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-50-S6-55. PubMed ID: 9151917
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy.
Seki T; Wakabayashi M; Nakagawa T; Imamura M; Tamai T; Nishimura A; Yamashiki N; Okamura A; Inoue K
Cancer; 1999 Apr; 85(8):1694-702. PubMed ID: 10223562
[TBL] [Abstract][Full Text] [Related]
20. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
